The administration of rt-PA (Activase®) for the treatment of empyema in an adult patient

Journal of Pharmacy Practice

Volumn 22, Issue 1, 2009, Pages 117-123

  Emerson, Christopher R ^a   Bercume, Christine M ^b   Antonopoulos, Marilena S ^a   Marzella, Nino ^a  

^a LONG ISLAND UNIVERSITY   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

Alteplase; Empyema; Pleural effusion; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; ANTIBIOTIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG MECHANISM; EMPYEMA; FIBRINOLYTIC THERAPY; HUMAN; MALE; THORAX DRAINAGE; TREATMENT OUTCOME;

EID: 58849141679     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190008329205     Document Type: Article

References (18)

1. Sahn SA Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax. 1998 ; 53 (suppl 2). 565-572.
2. LeMense GP, Strange C., Sahn SA Empyema thoracis. Therapeutic management and outcome. Chest. 1995 ; 107: 1532-1537.
3. Ray TL, Berkenbosch JW, Russo P., et al. Tissue plasminogen activator as an adjuvant therapy for peural empyema in pediatric patients. J Intensive Care Med. 2004 ; 19: 44-50.
4. Light RM Clinical practice. Pleural effusion. N Engl J Med. 2002 ; 346: 1971-1977.
5. Porcel JM, Light RW Diagnostic approach to pleural effusion in adults. Am Fam Physician. 2006 ; 73: 1211-1220.
6. Davies CW, Gleeson FV, Davies F. BTS guidelines for the management of pleural infection. Thorax. 2003 ; 58 (suppl II). ii18 - ii28.
7. Colice GL, Curtis A., Deslauriers J., et al. Medical and surgical treatment of parapneumonic effusions: an evidence based guideline. Chest. 2000 ; 118: 1158-1171.
8. Tillet WS, Sherry S. Effect in patients of streptococcal desoxyribonuclease on fibrinolysis in (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous exudations. J Clin Invest. 1949 ; 28: 173-186.
9. Tokuda Y., Matsushima D., Stein GH, et al. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions-a meta-analysis. Chest. 2006 ; 129: 783-790.
10. Davies RJ, Traill ZC, Gleeson FV Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997 ; 52: 416-421.
11. Diacon AH, Theron J., Schuurmans MM, et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med. 2004 ; 170: 49-53.
12. Davies CW, Kearney SE, Gleeson FV, et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999 ; 160: 1682-1687.
13. Maskell NA, Davies CWH, Nunn AJ, et al, for the First Multicenter Intrapleural Sepsis Trial (MIST1) Group. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005 ; 352: 865-874.
14. Wells RG, Havens PL Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology. 2003 ; 228: 370-378.
15. Weinstein M., Restrepo R., Chait PG, et al. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions. Pediatrics. 2004 ; 113: e182 - e185.
16. Thommi G., Nair CK, Aronow WS, et al. Efficacy and safety of intrapleural instillation of Alteplase in the management of complicated pleural effusion or empyema. Am J Ther. 2007 ; 14: 341-345.
17. Walker CA, Shirk MB, Tschampel MM, et al. Intrapleural alteplase in a patient with complicated pleural effusion. Ann Pharmacother. 2003 ; 37: 376-379.
18. Aleman C., Alegre J., Monasterio J., et al. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci. 2003 ; 105: 601-607.